Evidence map›Paper›PMID 38596320›Full record

ArticleJournal of the American College of Emergency Physicians open2024

Timing of antibiotic treatment identifies distinct clinical presentations among patients presenting with suspected septic shock.

Priya A Prasad, Armond M Esmaili, Sandra Oreper, Alexander J Beagle, Colin Hubbard, Katie E Raffel, Yumiko Abe-Jones, Margaret C Fang, Kathleen D Liu, Michael A Matthay and 1 more

Abstract read
In one paragraph

Article in Journal of the American College of Emergency Physicians open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Priya A PrasadDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.ORCID https://orcid.org/0000-0002-1384-0960
Armond M EsmailiDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.
Sandra OreperDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.
Alexander J BeagleDepartment of Medicine University of California San Francisco California USA.
Colin HubbardDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.
Katie E RaffelDivision of Hospital Medicine School of Medicine University of Colorado Denver Colorado USA.
Yumiko Abe-JonesDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.
Margaret C FangDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.
Kathleen D LiuDivision of Pulmonary and Critical Care Medicine Department of Medicine University of California San Francisco California USA.
Michael A MatthayDivision of Pulmonary and Critical Care Medicine Department of Medicine University of California San Francisco California USA.
Kirsten N KangelarisDivision of Hospital Medicine Department of Medicine University of California San Francisco California USA.

Funding

Prevention and Early Treatment of Acute Lung InjuryU01HL123004 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2014 to 2020
$2.6M
Advancing acute kidney injury phenotyping using biological and clinical criteriaK24DK113381 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIU, KATHLEEN D · 2017 to 2021
$915k
Use and outcomes of anticoagulants for the treatment and prevention of thrombosis among hospitalized patientsK24HL141354 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FANG, MARGARET C. · 2018 to 2022
$731k
NHLBI NIH HHS K24 HL141354NHLBI NIH HHS U01 HL123004NIDDK NIH HHS K24 DK113381
6 · The paper itself

Abstract

Objective: Recent clinical guidelines for sepsis management emphasize immediate antibiotic initiation for suspected septic shock. Though hypotension is a high-risk marker of sepsis severity, prior studies have not considered the precise timing of hypotension in relation to antibiotic initiation and how clinical characteristics and outcomes may differ. Our objective was to evaluate antibiotic initiation in relation to hypotension to characterize differences in sepsis presentation and outcomes in patients with suspected septic shock. Methods: Adults presenting to the emergency department (ED) June 2012-December 2018 diagnosed with sepsis (Sepsis-III electronic health record [EHR] criteria) and hypotension (non-resolving for ≥30 min, systolic blood pressure <90 mmHg) within 24 h. We categorized patients who received antibiotics before hypotension ("early"), 0-60 min after ("immediate"), and >60 min after ("late") treatment. Results: Among 2219 patients, 55% received early treatment, 13% immediate, and 32% late. The late subgroup often presented to the ED with hypotension (median 0 min) but received antibiotics a median of 191 min post-ED presentation. Clinical characteristics notable for this subgroup included higher prevalence of heart failure and liver disease ( Conclusions: There was significant heterogeneity in presentation and timing of antibiotic initiation for suspected septic shock. Patients with later treatment commonly had hypotension on presentation, had more hypotension-associated comorbidities, and developed overt markers of infection (eg, SIRS) later. While these factors likely contribute to delays in clinician recognition of suspected septic shock, it may not impact sepsis outcomes.

Indexed as

critical careelectronic health recordsemergency medicineorgan dysfunction scoressepsissystemic inflammatory response syndrome

Identifiers

PMID38596320
PMCPMC11002635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.